Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatoryfdahhscompoundingrfk-jr

Trump administration advances plan to let pharmacies compound certain peptides

STAT reports federal health officials are moving ahead on access for injections that sit largely outside FDA oversight.

DO
By Daniel Okafor · Regulatory Correspondent
Oct 15 16:46 ETSource: STAT

The wire

  1. 01U.S. health officials are advancing a plan that would allow specialty pharmacies to produce certain peptides, a class of largely unregulated injections, STAT reports.
  2. 02Compounders, telehealth operators and clinicians have been waiting on federal clarity before expanding peptide offerings beyond the gray market.
  3. 03Health secretary Robert F. Kennedy Jr. has favored the class; the policy's scope, which peptides are covered and its timing are not yet public.

From the source

Trump administration advances plan for peptide drugs favored by RFK Jr.

U.S. health officials are moving ahead with a plan to allow specialty pharmacies to produce certain peptides, a class of largely unregulated injections favored by health secretary Robert F. Kennedy…

Read at statnews.com
PeptiPrescribed peptides from $99/moSee all →